82 related articles for article (PubMed ID: 3545730)
1. Ciprofloxacin: a comparative evaluation of its bactericidal activity in human serum against four enterobacterial species.
Weiss D; Trautmann M; Wagner J; Borner K; Hahn H
Drugs Exp Clin Res; 1986; 12(11):889-94. PubMed ID: 3545730
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal activity of tigemonam, alone and in combination with gentamicin.
Shah PM; Gänger-Farshid G; Mulert R; Stille W
J Chemother; 1989 May; 1 Suppl 2():45-8. PubMed ID: 2809703
[TBL] [Abstract][Full Text] [Related]
3. [Bactericidal effect of cefotaxime-sulbactam and imipenem combined with gentamicin and/or ciprofloxacin against CTX-1 producing Klebsiella pneumoniae].
Archambaud M; Labau E; Clave D; Suc C
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):534-9. PubMed ID: 2677925
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial activity of gentamicin and ciprofloxacin against Gram-negative bacteria: interactions with pig and calf sera.
Miglioli PA; Silini R; Carzeri O; Grabocka E; Allerberger F
Pharmacol Res; 1999 Apr; 39(4):321-3. PubMed ID: 10208763
[TBL] [Abstract][Full Text] [Related]
5. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
Nijssen S; Florijn A; Bonten MJ; Schmitz FJ; Verhoef J; Fluit AC
Int J Antimicrob Agents; 2004 Dec; 24(6):585-91. PubMed ID: 15555882
[TBL] [Abstract][Full Text] [Related]
6. Effect of ceftazidime, amikacin and ciprofloxacin on biofilm formation by some enterobacterial clinical isolates.
Bret L; Di Martino P
Chemotherapy; 2004 Nov; 50(5):255-9. PubMed ID: 15528892
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa.
Klepser ME; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH
Antimicrob Agents Chemother; 1995 Nov; 39(11):2503-10. PubMed ID: 8585734
[TBL] [Abstract][Full Text] [Related]
8. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
Ismaeel NA; Tayeb OS
Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
[TBL] [Abstract][Full Text] [Related]
9. Comparative serum bactericidal activity against Pseudomonas aeruginosa of six antipseudomonal agents.
Dan M; Zabeeda D; Poch F
Chemotherapy; 1995; 41(5):323-9. PubMed ID: 8521732
[TBL] [Abstract][Full Text] [Related]
10. Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species.
DeRyke CA; Sutherland C; Zhang B; Nicolau DP; Kuti JL
Antimicrob Agents Chemother; 2006 Nov; 50(11):3529-34. PubMed ID: 17065618
[TBL] [Abstract][Full Text] [Related]
11. [In vitro bactericidal effect of cefotetan-aminoside combinations].
Thabaut A; Meyran M
Pathol Biol (Paris); 1988 May; 36(5):361-5. PubMed ID: 3043329
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004).
Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2007 May; 58(1):27-32. PubMed ID: 17383140
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of ciprofloxacin against gram-positive cocci.
Barry AL; Jones RN
Am J Med; 1987 Apr; 82(4A):27-32. PubMed ID: 3578323
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Cha R
Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
[TBL] [Abstract][Full Text] [Related]
15. Rapid assessment of ceftazidime, ciprofloxacin, and gentamicin susceptibility in exponentially-growing E. coli cells by means of flow cytometry.
Walberg M; Gaustad P; Steen HB
Cytometry; 1997 Feb; 27(2):169-78. PubMed ID: 9012384
[TBL] [Abstract][Full Text] [Related]
16. In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae.
Burgess DS; Hall RG
Diagn Microbiol Infect Dis; 2004 May; 49(1):41-6. PubMed ID: 15135499
[TBL] [Abstract][Full Text] [Related]
17. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
Chen MJ; Wang H;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic activity of garenoxacin against ciprofloxacin-resistant Streptococcus pneumoniae.
Zhanel GG; James J; Derkatch S; Laing N; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2006 Jul; 58(1):112-6. PubMed ID: 16644764
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity of isepamicin (SCH21420, 1-N-HAPA gentamicin B) combinations with cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, imipenem, mezlocillin and piperacillin tested against gentamicin-resistant and susceptible gram-negative bacilli and enterococci.
Jones RN; Johnson DM; Barrett MS; Erwin ME
J Chemother; 1991 Oct; 3(5):289-94. PubMed ID: 1809808
[TBL] [Abstract][Full Text] [Related]
20. [Pseudomonas aeruginosa: bactericidal activity on various beta-lactam resistance phenotypes of 8 antibiotics and 7 combinations].
Dubrous P; Cavallo JD; Hernandez E; Nordmann P; Fabre R
Pathol Biol (Paris); 1997 May; 45(5):433-7. PubMed ID: 9296099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
